[1] ALTIERI D C.Validating survivin as a cancer therapeutic target[J].Nat Rev Cancer,2003,3(1):46-54.
[2] YAMASHITA S,MASUDA Y,KURIZAKI T,et al.Survivin expression predicts early recurrence in early-stage breast cancer[J].Anticancer Res,2007,27(4C):2803-2808.
[3] 张保宁.乳腺癌临床研究的回顾与展望[J].中华医学杂志,2005,81(1):1-5.
[4] 何声秀,吕丽荣.转移性乳腺癌化疗进展[J].现代诊断与治疗,2002,13(3):155-158.
[5] OLIE R A,SIMOES-WUST A P,BAUMAN B,et al.A novel antisense oligonucleotide targeting survivin expression induces apoptosis and sensitizes lung cancer cells to chemotherapy[J].Cancer Res,2000,60(11):2805-2809.
[6] HOU J Q,HE J,WEN D G,et al.Survivin mRNA expression in urine as a biomarker for patients with transitional cell carcinoma of bladder[J].CMJ,2006,119(13):1118-1120.
[7] CALADS H,JIANG Y,HOLLOWAY M P,et al.Survivin splice variants regulate the balance between proliferation and cell death[J].Oncogene,2005,24(12):1994-2007.
[8] ANGELL H.A study into the potential role of survivin localization in resistance to drug-induced apoptosis[J].Bioscience Horizons,2008,1(2):85-91.
[9] NABHOLTZ J M,RESSE D M,LINDSAY M A,et al.Evidence for the use of chemotherapy in breast cancer[J].Int J Clin Oncol,2002,7( 4):254-264. |